Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Berman

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Virology|January 1, 1991
The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranesO K Haffar, D J Dowbenko, P W Berman
The Journal of Cell Biology|November 1, 1988
Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranesO K Haffar, D J Dowbenko, P W Berman
AIDS Research and Human Retroviruses|February 1, 1988
Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individualsJ W Torseth, P W Berman, T C Merigan
Journal of Virology|June 1, 1990
The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell linesO K Haffar, G R Nakamura, P W Berman
Journal of Virology|September 1, 1988
Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell linesP W Berman, W M Nunes, O K Haffar
Science (New York, N.Y.)|March 22, 1985
Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein DP W Berman, T Gregory, D Crase, et al.
Science (New York, N.Y.)|November 4, 1983
Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein DP W Berman, D Dowbenko, L A Lasky, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, E Y Yang, R B Belshe, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Factors affecting the susceptibility of different strains of mice to experimental myasthenia gravisP W Berman, J Patrick, S Heinemann, et al.
Journal of Virology|March 1, 1987
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cellsS Martin, B Moss, P W Berman, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Virology|January 1, 1991
The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranesO K Haffar, D J Dowbenko, P W Berman
The Journal of Cell Biology|November 1, 1988
Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranesO K Haffar, D J Dowbenko, P W Berman
AIDS Research and Human Retroviruses|February 1, 1988
Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individualsJ W Torseth, P W Berman, T C Merigan
Journal of Virology|June 1, 1990
The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell linesO K Haffar, G R Nakamura, P W Berman
Journal of Virology|September 1, 1988
Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell linesP W Berman, W M Nunes, O K Haffar
Science (New York, N.Y.)|March 22, 1985
Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein DP W Berman, T Gregory, D Crase, et al.
Science (New York, N.Y.)|November 4, 1983
Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein DP W Berman, D Dowbenko, L A Lasky, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, E Y Yang, R B Belshe, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Factors affecting the susceptibility of different strains of mice to experimental myasthenia gravisP W Berman, J Patrick, S Heinemann, et al.
Journal of Virology|March 1, 1987
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cellsS Martin, B Moss, P W Berman, et al.
Pageof 6